MATERNUS-KLINIKEN AG (MAK.DE) Stock Earnings & Estimates
Europe - FRA:MAK - DE0006044001 - Common Stock
1.1 EUR
+0.02 (+1.85%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | ||
|---|---|---|---|---|
| Revenue YoY % growth | 106.697M -4.25% | 102.306M -4.12% | 114.004M 11.43% | |
| EBITDA YoY % growth | 1.664M -89.72% | 4.452M 167.55% | 10.272M 130.73% | |
| EBIT YoY % growth | -9.351M -284.66% | -5.293M 43.40% | -2.284M 56.85% | |
| Operating Margin | -8.76% | -5.17% | -2.00% | |
| EPS YoY % growth | N/A | N/A | N/A |
All data in EUR
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in EUR
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 59.3M 3.79% | % | ||
| Q4 2024 Q2Q % growth | 56.872M -44.41% | % | ||
| Q2 2024 Q2Q % growth | 57.132M 124.88% | % | ||
| Q4 2023 Q2Q % growth | 102.306M -4.12% | % | ||
| Q2 2023 Q2Q % growth | 25.405M -11.93% | % | ||
| Q1 2023 Q2Q % growth | 25.326M -2.98% | % | ||
| Q4 2022 Q2Q % growth | 106.697M -4.25% | % | ||
| Q2 2022 Q2Q % growth | 28.847M 2.13% | % | ||
| Q4 2021 Q2Q % growth | 111.437M -2.50% | % | ||
| Q2 2021 Q2Q % growth | 28.245M 3.96% | % | ||
| Q4 2020 Q2Q % growth | 114.299M 84.39% | % | ||
| Q2 2020 Q2Q % growth | 27.17M -13.85% | % | ||
| Q1 2020 Q2Q % growth | 28.064M -9.19% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |